MS
MSN Laboratories
Hyderabad INFounded 20047,000 employees
Private CappharmaPrivateOncology
Platform: Generic API
Market Cap
N/A
All Drugs
3
Clinical Trials
4
Failed / Terminated
0
FDA Approved
1
Drug Pipeline (3 programs)
| Drug Name | Code | Phase | Trials | Modality | Target | MOA | Indications |
|---|---|---|---|---|---|---|---|
| Pemicagene | MSN-6933 | Approved | 1 | IL-13 | EpilepsyFSGS | ||
| Rilunaritide | MSN-8921 | Phase 1 | 1 | Aβ | FTDPNH | ||
| MSN-5549 | MSN-5549 | NDA/BLA | 2 | FcRn | UCGIST |
Financial Documents
This is a private company — SEC filings are not available.
Catalyst Events (4)